We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
brainspark clearly has a motive to get the SP lower otherwise what's the point of his negative comments ?
Ignore.
The money always runs out at some point. It’s what you spend it on that counts...
“The net proceeds of the Fundraising, together with the Company's existing resources, are expected to support its ongoing clinical studies in IBS and oncology and to enable the Company to continue to fund its operations to at least two clinical study readouts (as detailed further below), as well as for general corporate purposes.
Subject to reporting positive data from these studies, the Company believes these will provide a material validation for its approach to developing LBPs and also serve as value accretive events for Shareholders.”
So two clinical readouts, one of which is IBS.
Note also that the directors in for two million at 50p and the supporting warrants aren’t redeemable for 5yrs and then at 100p.
IBS is the main event here imo. Positive results there and it’s a takeover but they also have 6 other trials!
Trek
brainspark
I think every bio I've ever invested in has issued an RNS on dosing the first patient in a clinical trial. The news this morning marks an important milestone in the progress of this study and the development of MRx0518 and it's quite right and proper that it should be communicated to the market via RNS .
Money runs out in Q4. FACT
That was always their aim (excuse the pun) to take it to a bigger study and now it's been officially confirmed and with substantiated numbers.
Nice deramp about the placing....they're fine with money and esp as they have the backing of Merck!
It was in their presentation on their website for over 4 weeks!
They must be looking at a placing if they are putting out old news. Money runs out in 3 months time
It's not old news...read the RNS and previous RNS!!!!!!
They haven't
Why have they RNSed old news?